Jim Cramer's Mad Dash: How Healthy Is CVS?

NEW YORK (TheStreet) -- Shares of CVS Caremark (CVS) are muted after the company released its first-quarter earnings. Although the company beat on revenue estimates, TheStreet's Jim Cramer, co-manager of the Action Alerts PLUS portfolio, was more concerned about the company's declining same-store sales, which fell 3.8%.

"That took my breath away," he said on CNBC's "Cramer's Mad Dash" segment Friday. 

Investors have to know why same-store sales decline so much, especially since Rite-Aid (RAD), which many consider a "second-rate CVS," saw same-store sales climb 4.7%, he said. 

Rite-Aid and CVS have many similar locations, likely making some investors wonder if Rite-Aid is taking market share from CVS. 

However, don't write off CVS just yet. It's "a great company" and could be a buying opportunity, Cramer concluded. He just wants to know why same-store sales declined so meaningfully.


-- Written by Bret Kenwell in Petoskey, Mich.

At the time of publication, Cramer's Action Alerts PLUS had no position in companies mentioned.

More from Opinion

Throwback Thursday: Tesla, Chip Stocks, TheStreet's Picks

Throwback Thursday: Tesla, Chip Stocks, TheStreet's Picks

12 Stocks That Our Writers and Their Sources Recommend You Buy Here

12 Stocks That Our Writers and Their Sources Recommend You Buy Here

Musk Goes on Unoriginal Media Tirade

Musk Goes on Unoriginal Media Tirade

What's Happening in Video Games This Week: On the Road to E3

What's Happening in Video Games This Week: On the Road to E3

Wednesday Wrap-Up: Let's Talk About General Electric

Wednesday Wrap-Up: Let's Talk About General Electric